Annual Gross Profit
$19.66 B
-$952.16 M-4.62%
March 31, 2024
Summary
- As of February 12, 2025, TAK annual gross profit is $19.66 billion, with the most recent change of -$952.16 million (-4.62%) on March 31, 2024.
- During the last 3 years, TAK annual gross profit has fallen by -$1.13 billion (-5.41%).
- TAK annual gross profit is now -10.36% below its all-time high of $21.93 billion, reached on March 31, 2022.
Performance
TAK Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$4.77 B
-$494.99 M-9.41%
December 1, 2024
Summary
- As of February 12, 2025, TAK quarterly gross profit is $4.77 billion, with the most recent change of -$494.99 million (-9.41%) on December 1, 2024.
- Over the past year, TAK quarterly gross profit has dropped by -$494.99 million (-9.41%).
- TAK quarterly gross profit is now -26.32% below its all-time high of $6.47 billion, reached on June 30, 2021.
Performance
TAK Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$19.80 B
-$187.64 M-0.94%
December 1, 2024
Summary
- As of February 12, 2025, TAK TTM gross profit is $19.80 billion, with the most recent change of -$187.64 million (-0.94%) on December 1, 2024.
- Over the past year, TAK TTM gross profit has dropped by -$187.64 million (-0.94%).
- TAK TTM gross profit is now -10.44% below its all-time high of $22.11 billion, reached on September 30, 2021.
Performance
TAK TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
TAK Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.6% | -9.4% | -0.9% |
| 3 y3 years | -5.4% | -2.6% | -3.8% |
| 5 y5 years | +50.8% | -2.3% | -4.8% |
TAK Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | at low | -12.6% | +5.9% | -9.9% | +1.2% |
| 5 y | 5-year | -10.4% | +50.8% | -26.3% | +5.9% | -10.4% | +2.1% |
| alltime | all time | -10.4% | +344.3% | -26.3% | +95.3% | -10.4% | +527.0% |
Takeda Pharmaceutical Company Limited Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $4.77 B(-9.4%) | $19.80 B(-0.9%) |
| Sep 2024 | - | $5.26 B(-0.1%) | $19.99 B(+2.1%) |
| Jun 2024 | - | $5.27 B(+17.0%) | $19.57 B(-0.5%) |
| Mar 2024 | $19.66 B(-4.6%) | $4.50 B(-9.1%) | $19.68 B(-1.9%) |
| Dec 2023 | - | $4.96 B(+2.3%) | $20.07 B(-2.1%) |
| Sep 2023 | - | $4.84 B(-9.9%) | $20.51 B(-1.0%) |
| Jun 2023 | - | $5.37 B(+9.8%) | $20.71 B(+0.6%) |
| Mar 2023 | $20.61 B(-6.0%) | $4.89 B(-9.3%) | $20.58 B(+0.2%) |
| Dec 2022 | - | $5.39 B(+6.9%) | $20.55 B(-0.3%) |
| Sep 2022 | - | $5.04 B(-3.8%) | $20.60 B(-0.6%) |
| Jun 2022 | - | $5.24 B(+7.9%) | $20.73 B(-5.6%) |
| Mar 2022 | $21.93 B(+5.5%) | $4.86 B(-10.8%) | $21.96 B(-0.1%) |
| Dec 2021 | - | $5.45 B(+5.5%) | $21.97 B(-0.6%) |
| Sep 2021 | - | $5.17 B(-20.1%) | $22.11 B(+0.4%) |
| Jun 2021 | - | $6.47 B(+32.6%) | $22.02 B(+5.9%) |
| Mar 2021 | $20.79 B(+2.6%) | $4.88 B(-12.7%) | $20.79 B(+0.4%) |
| Dec 2020 | - | $5.59 B(+10.0%) | $20.72 B(+1.3%) |
| Sep 2020 | - | $5.08 B(-3.0%) | $20.46 B(+0.2%) |
| Jun 2020 | - | $5.24 B(+9.0%) | $20.42 B(+0.8%) |
| Mar 2020 | $20.25 B(+55.3%) | $4.81 B(-9.8%) | $20.25 B(+4.4%) |
| Dec 2019 | - | $5.33 B(+5.7%) | $19.40 B(+12.3%) |
| Sep 2019 | - | $5.04 B(-0.6%) | $17.27 B(+14.4%) |
| Jun 2019 | - | $5.07 B(+28.3%) | $15.10 B(+15.7%) |
| Mar 2019 | $13.04 B(+13.3%) | $3.95 B(+23.5%) | $13.04 B(+10.9%) |
| Dec 2018 | - | $3.20 B(+11.5%) | $11.77 B(+1.2%) |
| Sep 2018 | - | $2.87 B(-4.9%) | $11.63 B(+0.6%) |
| Jun 2018 | - | $3.02 B(+12.8%) | $11.56 B(+0.6%) |
| Mar 2018 | $11.50 B(+6.0%) | $2.68 B(-12.6%) | $11.49 B(+1.8%) |
| Dec 2017 | - | $3.06 B(+9.1%) | $11.29 B(+1.4%) |
| Sep 2017 | - | $2.81 B(-4.7%) | $11.14 B(+1.1%) |
| Jun 2017 | - | $2.95 B(+18.9%) | $11.02 B(+1.7%) |
| Mar 2017 | $10.85 B(+2.3%) | $2.48 B(-14.8%) | $10.84 B(+0.3%) |
| Dec 2016 | - | $2.91 B(+8.2%) | $10.81 B(+0.7%) |
| Sep 2016 | - | $2.69 B(-2.7%) | $10.73 B(+0.6%) |
| Jun 2016 | - | $2.76 B(+13.2%) | $10.67 B(+0.8%) |
| Mar 2016 | $10.60 B | $2.44 B(-13.8%) | $10.59 B(-1.0%) |
| Dec 2015 | - | $2.83 B(+7.7%) | $10.69 B(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $2.63 B(-1.8%) | $10.91 B(-3.2%) |
| Jun 2015 | - | $2.68 B(+5.3%) | $11.27 B(-1.6%) |
| Mar 2015 | $11.49 B(-4.2%) | $2.55 B(-16.6%) | $11.46 B(-1.9%) |
| Dec 2014 | - | $3.05 B(+2.0%) | $11.68 B(-1.7%) |
| Sep 2014 | - | $2.99 B(+4.4%) | $11.89 B(-0.1%) |
| Jun 2014 | - | $2.87 B(+3.9%) | $11.90 B(-0.8%) |
| Mar 2014 | $12.00 B(-9.3%) | $2.76 B(-15.2%) | $11.99 B(+1.3%) |
| Dec 2013 | - | $3.26 B(+8.3%) | $11.84 B(-1.7%) |
| Sep 2013 | - | $3.01 B(+1.7%) | $12.05 B(-4.0%) |
| Jun 2013 | - | $2.96 B(+13.3%) | $12.55 B(-5.4%) |
| Mar 2013 | $13.23 B(-2.9%) | $2.61 B(-24.7%) | $13.27 B(-4.2%) |
| Dec 2012 | - | $3.47 B(-1.1%) | $13.85 B(-1.0%) |
| Sep 2012 | - | $3.51 B(-4.7%) | $14.00 B(+0.8%) |
| Jun 2012 | - | $3.68 B(+15.2%) | $13.89 B(+2.0%) |
| Mar 2012 | $13.63 B(+6.5%) | $3.20 B(-11.6%) | $13.63 B(+0.7%) |
| Dec 2011 | - | $3.61 B(+6.1%) | $13.53 B(+1.4%) |
| Sep 2011 | - | $3.40 B(-0.2%) | $13.35 B(+0.9%) |
| Jun 2011 | - | $3.41 B(+9.9%) | $13.22 B(+2.7%) |
| Mar 2011 | $12.80 B(+0.5%) | $3.10 B(-9.4%) | $12.87 B(+1.2%) |
| Dec 2010 | - | $3.43 B(+4.5%) | $12.71 B(+0.8%) |
| Sep 2010 | - | $3.28 B(+7.1%) | $12.61 B(-0.1%) |
| Jun 2010 | - | $3.06 B(+3.8%) | $12.62 B(-0.8%) |
| Mar 2010 | $12.73 B(+1.3%) | $2.95 B(-11.2%) | $12.71 B(+0.7%) |
| Dec 2009 | - | $3.32 B(+0.9%) | $12.62 B(-0.6%) |
| Sep 2009 | - | $3.29 B(+4.1%) | $12.70 B(+1.0%) |
| Jun 2009 | - | $3.16 B(+10.5%) | $12.57 B(+33.5%) |
| Mar 2009 | $12.56 B(+30.6%) | $2.86 B(-15.9%) | $9.41 B(+43.6%) |
| Dec 2008 | - | $3.40 B(+7.6%) | $6.56 B(+107.6%) |
| Sep 2008 | - | $3.16 B | $3.16 B |
| Mar 2008 | $9.62 B(+9.7%) | - | - |
| Mar 2007 | $8.77 B(+6.6%) | - | - |
| Mar 2006 | $8.23 B(+4.6%) | - | - |
| Mar 2005 | $7.86 B(+8.5%) | - | - |
| Mar 2004 | $7.25 B(+18.3%) | - | - |
| Mar 2003 | $6.13 B(+14.6%) | - | - |
| Mar 2002 | $5.34 B(+1.8%) | - | - |
| Mar 2001 | $5.25 B(+18.7%) | - | - |
| Mar 2000 | $4.43 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual gross profit?
- What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit?
- What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM gross profit?
- What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
What is Takeda Pharmaceutical Company Limited annual gross profit?
The current annual gross profit of TAK is $19.66 B
What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual gross profit is $21.93 B
What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
Over the past year, TAK annual gross profit has changed by -$952.16 M (-4.62%)
What is Takeda Pharmaceutical Company Limited quarterly gross profit?
The current quarterly gross profit of TAK is $4.77 B
What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly gross profit is $6.47 B
What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
Over the past year, TAK quarterly gross profit has changed by -$494.99 M (-9.41%)
What is Takeda Pharmaceutical Company Limited TTM gross profit?
The current TTM gross profit of TAK is $19.80 B
What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM gross profit is $22.11 B
What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
Over the past year, TAK TTM gross profit has changed by -$187.64 M (-0.94%)